All Q2 FY26 results →

OH

Omega Healthcare Investors, Inc.

Q2 FY26Health Care REITs

Omega Healthcare Investors, Inc. Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹47

Market cap₹14.0K Cr

P/E23.4

Updated29 May 2026

Read4 min read

What the Q2 FY26 call signalled

2 of 4 strong

RevenueModerate growth

MarginMargins steady

CapexCapex planned

FundraiseFundraise planned

The short version

- Skilled nursing facilities (SNFs) expected to grow at a high single-digit to low double-digit rate annually, supported by organic growth and new acquisitions (Page 10). - First quarter 2026 FAD per share increased 9.5% year-over-year, reflecting strong growth.

From Omega Healthcare Investors, Inc.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Moderate growth

Skilled nursing facilities (SNFs) expected to grow at a high single-digit to low double-digit rate annually, supported by organic growth and new acquisitions (Page 10).
Senior Housing RIDEA (Rental Income Dependent on Earnings Arrangement) platform growth is focused on value-add opportunities with mid-teen IRRs targeted, supported by strong underwriting and operator expertise (Pages 7, 13).
Maplewood portfolio experienced high single-digit rent increases in Q1, with expected ongoing revenue growth tied to escalators and portfolio stability (Page 12).

2 more points from Omega Healthcare Investors, Inc.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

First quarter 2026 FAD per share increased 9.5% year-over-year, reflecting strong growth.
Full-year adjusted AFFO guidance raised to a midpoint of $3.22 per share, up $0.02 from prior guidance.
Capital redeployment from $480 million in planned asset sales expected to add approximately $0.03 annual AFFO and FAD accretion.
Growth driven by acquisitions in RIDEA, skilled nursing, senior housing, and U.K. care homes, targeting mid-teens IRRs.
Dividend payout ratio lowered to 82% of AFFO and 86% of FAD, signaling potential dividend growth.
Board likely to discuss dividend increases by year-end 2026 as capital recycling accelerates and portfolio stabilizes.

2 more points from Omega Healthcare Investors, Inc.'s call on margins

Create a free account to keep reading this call

See what Omega Healthcare Investors, Inc. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

Omega completed $251 million in new investments in Q1 2026, excluding $13 million in CapEx.
New investments include a 9.9% equity interest acquisition in Saber’s operating company.
Total transaction activity for 2026 started strong with $326 million in new investments year-to-date.
Investments span U.S. skilled nursing, U.K. care home, and senior housing RIDEA portfolios.
The company focuses on accretive transactions to grow FAD per share sustainably.
Hiring efforts include building out teams for SHOP RIDEA to improve underwriting, asset management, and sourcing opportunities.

2 more points from Omega Healthcare Investors, Inc.'s call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

The company is open to creative capital structures including debt that can convert to equity over time, indicating flexibility in fundraising methods.
They are focused on capital recycling and investing excess cash flow into new opportunities.
Asset sales, such as the $480 million Communicare portfolio, are part of capital allocation but not a core ongoing strategy.
The company funds loans, e.g., committing up to $26.7 million for Genesis DIP loan advances.

2 more points from Omega Healthcare Investors, Inc.'s call on fundraising

Create a free account to keep reading this call

See what Omega Healthcare Investors, Inc. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Transaction activity in 2026 started strong with $326 million in new investments year-to-date (including $13 million in CapEx).
Completed $251 million in new investments in Q1 2026, including $109 million acquisition of 13 assets and 9.9% equity interest in Saber’s operating company.
Active pipeline with ongoing efforts to source off-market deals, especially in the U.K. and U.S., supported by new hires in asset management and accounting.
Robust pipeline projected over the next 24 months across senior housing, skilled nursing, and care homes, despite a competitive market.

2 more points from Omega Healthcare Investors, Inc.'s call on order book

Create a free account to keep reading this call

Others in Health Care REITs this season

Healthpeak Properties, Inc. (Q2 FY26)
Healthpeak Properties, Inc. Q2 FY26 quarterly results analysis. **Life Science Occupancy Growth:** Expect total life science occupancy to increase by at least 1
Ventas, Inc. (Q2 FY26)
Ventas, Inc. Q2 FY26 quarterly results analysis. Ventas expects continued strong growth in senior housing, with SHOP same-store NOI growth projected at 16% midp

Compare:vs Ventas, Inc.vs Healthpeak Properties, Inc.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Omega Healthcare Investors, Inc. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Omega Healthcare Investors, Inc. Q2 FY26 results?

- Skilled nursing facilities (SNFs) expected to grow at a high single-digit to low double-digit rate annually, supported by organic growth and new acquisitions (Page 10). - First quarter 2026 FAD per share increased 9.5% year-over-year, reflecting strong growth.

What is Omega Healthcare Investors, Inc. share price analysis?

Omega Healthcare Investors, Inc. currently shows a below-average growth signal. The stock trades at a P/E of 23.4 with a market cap of $14,009. Investors should review the full earnings analysis for detailed insights.

Is Omega Healthcare Investors, Inc. planning capital expenditure?

- Omega completed $251 million in new investments in Q1 2026, excluding $13 million in CapEx. - New investments include a 9.9% equity interest acquisition in Saber’s operating company. - Total transaction activity for 2026 started strong with $326 million in new investments year-to-date. - Investments span U.S.

Keep Omega Healthcare Investors, Inc. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.